about
Altered cardiac electrophysiology and SUDEP in a model of Dravet syndromeEpileptic encephalopathies: new genes and new pathwaysGenetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndromeTemperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancyClinical review of genetic epileptic encephalopathiesSudden unexpected death in a mouse model of Dravet syndrome.Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.Seizures and epilepsy: an overview for neuroscientistsSporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females.Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsyImproving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform.Inherited neuronal ion channelopathies: new windows on complex neurological diseases.Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome.Severe Myoclonic Epilepsy in Infancy - Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases.Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome(1,2,3).When should clinicians order genetic testing for Dravet syndrome?Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy.Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.Outcome of convulsive status epilepticus: a review.Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice.A functional null mutation of SCN1B in a patient with Dravet syndrome.Epilepsy in childhood and adolescence.Physiologic alterations in ataxia: channeling changes into novel therapies.NaV1.1 channels and epilepsy.Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).Insights into pathophysiology and therapy from a mouse model of Dravet syndromeUpdate on rufinamide in childhood epilepsy.SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention.Traffic jam at the sodium channel.Occlusive patch therapy for reduction of seizures in Dravet syndrome.Seizure control in a patient with Dravet syndrome and cystic fibrosisDravet syndromeDrug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatmentForty Years of Sodium Channels: Structure, Function, Pharmacology, and Epilepsy.Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts.Can the combination of hyperthermia, seizures and ion channel dysfunction cause fatal post-ictal cerebral edema in patients with SCN1A mutations?Benign and severe early-life seizures: a round in the first year of life.
P2860
Q21089741-6016CC22-C520-425E-AC29-AAE4A4230E42Q27027982-A3058588-D675-425F-9D61-9DDF4F2C2C77Q27308208-5B8F17D4-BC6F-4DE5-91E3-3EA98623C98DQ30486496-A584DD9E-053C-4975-9119-B184F20D6D34Q30537230-90A8F69C-E880-4CFB-AC99-E0288600FFA0Q30538288-0B944112-8526-4BB8-B9DD-C483EB26F83EQ30572370-4C9FBB08-EB03-4664-80E3-883A5DE8787DQ33165796-ED68EA92-905F-4EB6-8EB1-2ED529C6B801Q33408779-6F34410A-F55E-48AF-9B08-A65766EB9F4CQ34478943-3005FC3F-B18B-4C63-8DFE-576AA7964D4FQ35079979-D97C4170-D905-4099-83DF-1BF348839D89Q35226085-5F0A1B8D-7FD9-4AD6-8EA1-F0A15CCE3364Q35472627-6BB75925-38D1-4760-A45C-8E6D16A2FC0DQ35546464-001501E4-DF86-464A-8152-911C960AF134Q35805872-43EDAF65-F126-432B-A9D0-92631D3F2503Q36460682-217DE8C6-4CCA-41BA-ACC7-FEF8D8D0E69FQ36672596-555CA20A-C86B-46B0-9557-25684DD41CBAQ36776559-967273E6-A974-4ED0-ACDE-81CE03428AFFQ36978559-FD07D40A-B4B3-44EF-8E96-86BC874C830EQ37179285-CB623730-99C6-4AF7-93CB-06C11157D97EQ37342533-6E1FD0B2-219E-4834-8A92-C3AB6001359CQ37359854-FFDBBB45-28EE-4656-B14F-3F2678B0ABB5Q37560645-826C720F-0CC8-40F9-BFDC-202D18A6015FQ37613322-5F4EC997-5A99-4BAB-B18D-CEFB4FE165EAQ37701079-0060BBA5-8C10-46AE-97E7-7C6B37C80436Q37717421-3F4D6F1C-87D5-414A-96D6-9116C53BB99BQ37861266-D67E5A50-8F92-411C-B789-535E4E885E7CQ37906275-B17E606F-0F1B-414F-AAE6-A34ABB912BE0Q37985147-63E9E256-FB90-49A2-9BF0-1D2C942AFA92Q38206101-4D9E2FA9-5B38-441C-8054-FF8433B47EDAQ38454078-83C8E99F-6AA5-46D3-8FDE-C135941B556BQ40465806-485A1D9B-000B-401B-96BF-01E5C924CF9BQ41455599-27382F9D-D2CF-427A-AB9E-AF105824B97FQ41867058-F9022FCB-581F-4D66-BE43-FCD6692F89F2Q41871259-D02BC6B8-52EF-46C5-91EC-A6AACC8F9983Q47288120-90C82001-CED8-404A-BAF4-A2CD009F3A72Q47736002-469069CE-138B-4362-B0AE-AD3D9584DF7FQ55091979-C34E02B7-8F87-49D2-9C9C-CF1D1C5A3926Q55294576-F4E1D174-05EA-4BC8-85C6-E38B04283370
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Severe myoclonic epilepsy in infancy: Dravet syndrome.
@ast
Severe myoclonic epilepsy in infancy: Dravet syndrome.
@en
type
label
Severe myoclonic epilepsy in infancy: Dravet syndrome.
@ast
Severe myoclonic epilepsy in infancy: Dravet syndrome.
@en
prefLabel
Severe myoclonic epilepsy in infancy: Dravet syndrome.
@ast
Severe myoclonic epilepsy in infancy: Dravet syndrome.
@en
P2093
P1476
Severe myoclonic epilepsy in infancy: Dravet syndrome
@en
P2093
Charlotte Dravet
Hirokazu Oguni
Michelle Bureau
Ozlem Cokar
Yukio Fukuyama
P304
P577
2005-01-01T00:00:00Z